carbamazepine
Generic: carbamazepine
Labeler: atlantic biologicals corpsDrug Facts
Product Profile
Brand Name
carbamazepine
Generic Name
carbamazepine
Labeler
atlantic biologicals corps
Dosage Form
SUSPENSION
Routes
Active Ingredients
carbamazepine 100 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
17856-4047
Product ID
17856-4047_30a4fdec-3fbc-034c-e063-6294a90aa786
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076729
Listing Expiration
2026-12-31
Marketing Start
2004-09-20
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
178564047
Hyphenated Format
17856-4047
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carbamazepine (source: ndc)
Generic Name
carbamazepine (source: ndc)
Application Number
ANDA076729 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/5mL
Packaging
- 10 mL in 1 CUP (17856-4047-1)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "30a4fdec-3fbc-034c-e063-6294a90aa786", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["308976"], "spl_set_id": ["25939406-a836-43cd-9301-56808e9b31ec"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Atlantic Biologicals Corps"]}, "finished": true, "packaging": [{"sample": false, "description": "10 mL in 1 CUP (17856-4047-1)", "package_ndc": "17856-4047-1", "marketing_start_date": "20150428"}], "brand_name": "Carbamazepine", "product_id": "17856-4047_30a4fdec-3fbc-034c-e063-6294a90aa786", "dosage_form": "SUSPENSION", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "17856-4047", "generic_name": "Carbamazepine", "labeler_name": "Atlantic Biologicals Corps", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "100 mg/5mL"}], "application_number": "ANDA076729", "marketing_category": "ANDA", "marketing_start_date": "20040920", "listing_expiration_date": "20261231"}